Establishment of drug screenine model based on transcriptional regulation of estrogen responsive element

Zhongguo Zhongyao Zazhi

Volumn 28, Issue 6, 2003, Pages 539-540

  Wang, Ling Qiao ^a   Lu, Qiu Jun ^a   Niu, Jian Zhao ^a   Wang, Jing Feng ^a   Qu, Yan Yan ^a   Wen, Li Qing ^a   Zheng, Long Tai ^a   Chen, Yuan Yuan ^a   Zhang, Ming ^a  

^a NONE

Author keywords

Drug screening; ER; ERE; Reporter gene

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; LIGAND;

ARTICLE; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; METHODOLOGY; PROMOTER REGION; REPORTER GENE;

DRUG EVALUATION, PRECLINICAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; GENES, REPORTER; GENISTEIN; HELA CELLS; HUMANS; LIGANDS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; TRANSFECTION;

EID: 24644458832     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mueller S O, Korach S K. Estrogen Receptors and Endocrine Diseases: Lessons from Estrogen Receptor Knochout Mice. Curr Opin Pharmacol, 2001, 1(6): 613.
2. Govind A P, Thampan R V. Proteins Interaction with the Mammalian Estrogen Receptor: Proposal for An Integrated Model for Estrogen Receptor Mediated Regulation of Transcription. J Cell Biochem, 2001, 80: 571.
3. White J H, McCualg K A, Mader S, et al. A Simple and Sensitive High-throughput Assay for Steroid Agonists and An TALgonists. J Biotechnology, 1994, 12(10): 1003.
4. Harrison R K, Lin S, Seidel H M, et al. Cell-free and Cell-based Methods for Characterizing Nuclear Receptor Ligands. Curr Med Chem Imun, Endoc & MeTALb Agents, 2002, 2(1): 23.
5. Sathya G, Li W, Klinge CM, et al. Effects of Multiple Estrogen Responsive Elements, Their Spacing and Location on Estrogen Response of Reporter genes. Molecular Endocrinology, 1997, 11 (13): 1994.
6. Shao Z Z, Shen Z Z, FonTALna J A, et al. Genisein's "ER-Dependent and Independent" Actions are Mediated Through ER Pathways in ER-positive Breast Carcinoma cell Lines. Anticancer Res, 2000,20:2049.